As Prices Soar, ADA Calls for Access to Affordable Insulin

Share this content:
As Prices Soar, ADA Calls for Access to Affordable Insulin
As Prices Soar, ADA Calls for Access to Affordable Insulin

TUESDAY, Nov. 29, 2016 (HealthDay News) -- In early November, Sen. Bernie Sanders, the Vermont Democrat, pointed out that certain insulins had risen from $21 a vial in 1996 to $255 a vial in 2016.

Others have taken notice of these increases, too. On Nov. 17, the American Diabetes Association (ADA) issued a call for Congress to investigate insulin pricing and come up with solutions so that patients with diabetes aren't facing financial hardship when purchasing the medication. The ADA said that in many areas in Europe, insulin costs one-sixth of what it does in the United States.

"Reasonable access to insulin has become a problem for some people with diabetes. This needs to change, and we are committed to doing our part to improve access," said a Nov. 18 statement from Lilly Diabetes. The company said it is exploring different ways to help patients who need the most assistance, particularly those with high-deductible health plans.

Another insulin manufacturer, Sanofi, described the problem another way. The company said in a written statement that the list price for its insulin drug Lantus hasn't increased since November 2014. "In fact, the net price of Lantus over the cumulative period of the last five years has decreased because of efforts to remain included on formularies at a favorable tier, which helps to reduce the out-of-pocket costs to patients," the Sanofi statement said. The statement added, "Sanofi is disappointed by recent decisions to exclude Lantus from formulary coverage. Health care professionals and patients should have a choice regarding their treatment and access to the right therapy to meet individual patient needs."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Adding HIPEC to Cytoreductive Surgery Beneficial in Ovarian CA

Adding HIPEC to Cytoreductive Surgery Beneficial in Ovarian ...

Longer survival with hyperthermic intraperitoneal chemotherapy in stage III epithelial ovarian cancer

Chaplains Effective in Facilitating Advance Care Planning

Chaplains Effective in Facilitating Advance Care Planning

80 percent of patients who met chaplains in medical practice completed or provided advance directive

Alzheimer's Disease Variants Linked to Brain Amyloidosis

Alzheimer's Disease Variants Linked to Brain Amyloidosis

Significant correlations found for adenosine triphosphate-binding cassette subfamily A member

is free, fast, and customized just for you!

Already a member?

Sign In Now »